1. Home
  2. HLI vs BMRN Comparison

HLI vs BMRN Comparison

Compare HLI & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

HOLD

Current Price

$139.37

Market Cap

9.6B

Sector

Finance

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$58.40

Market Cap

11.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLI
BMRN
Founded
1972
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
11.4B
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
HLI
BMRN
Price
$139.37
$58.40
Analyst Decision
Buy
Buy
Analyst Count
7
18
Target Price
$194.29
$88.22
AVG Volume (30 Days)
799.0K
1.7M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
1.54%
N/A
EPS Growth
6.87
N/A
EPS
6.22
0.54
Revenue
$2,617,516,000.00
$1,313,646,000.00
Revenue This Year
$13.77
$15.02
Revenue Next Year
$12.10
$12.23
P/E Ratio
$22.50
$109.80
Revenue Growth
9.55
17.62
52 Week Low
$130.72
$49.26
52 Week High
$211.78
$66.28

Technical Indicators

Market Signals
Indicator
HLI
BMRN
Relative Strength Index (RSI) 48.50 53.25
Support Level $133.57 $57.77
Resistance Level $144.54 $60.22
Average True Range (ATR) 4.26 1.44
MACD 0.56 -0.17
Stochastic Oscillator 57.26 36.16

Price Performance

Historical Comparison
HLI
BMRN

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: